Hodgson CP - Search Results

1

Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine.

Luke JM, Simon GG, Söderholm J, Errett JS, August JT, Gale M Jr, Hodgson CP, Williams JA. Luke JM, et al. Among authors: hodgson cp. J Virol. 2011 Feb;85(3):1370-83. doi: 10.1128/JVI.01250-10. Epub 2010 Nov 24. J Virol. 2011. PMID: 21106745 Free PMC article.

2

Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection system.

Luke J, Carnes AE, Hodgson CP, Williams JA. Luke J, et al. Among authors: hodgson cp. Vaccine. 2009 Oct 30;27(46):6454-9. doi: 10.1016/j.vaccine.2009.06.017. Epub 2009 Jun 24. Vaccine. 2009. PMID: 19559109 Free PMC article.

3

Improved antibiotic-free plasmid vector design by incorporation of transient expression enhancers.

Luke JM, Vincent JM, Du SX, Gerdemann U, Leen AM, Whalen RG, Hodgson CP, Williams JA. Luke JM, et al. Among authors: hodgson cp. Gene Ther. 2011 Apr;18(4):334-43. doi: 10.1038/gt.2010.149. Epub 2010 Nov 25. Gene Ther. 2011. PMID: 21107439 Free PMC article.

4

Inducible Escherichia coli fermentation for increased plasmid DNA production.

Carnes AE, Hodgson CP, Williams JA. Carnes AE, et al. Among authors: hodgson cp. Biotechnol Appl Biochem. 2006 Nov;45(Pt 3):155-66. doi: 10.1042/BA20050223. Biotechnol Appl Biochem. 2006. PMID: 16819941

5

Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.

Williams JA, Carnes AE, Hodgson CP. Williams JA, et al. Among authors: hodgson cp. Biotechnol Adv. 2009 Jul-Aug;27(4):353-70. doi: 10.1016/j.biotechadv.2009.02.003. Epub 2009 Feb 20. Biotechnol Adv. 2009. PMID: 19233255 Free PMC article. Review.

6

Generic plasmid DNA production platform incorporating low metabolic burden seed-stock and fed-batch fermentation processes.

Williams JA, Luke J, Langtry S, Anderson S, Hodgson CP, Carnes AE. Williams JA, et al. Among authors: hodgson cp. Biotechnol Bioeng. 2009 Aug 15;103(6):1129-43. doi: 10.1002/bit.22347. Biotechnol Bioeng. 2009. PMID: 19408315 Free PMC article.

7

Plasmid DNA production combining antibiotic-free selection, inducible high yield fermentation, and novel autolytic purification.

Carnes AE, Hodgson CP, Luke JM, Vincent JM, Williams JA. Carnes AE, et al. Among authors: hodgson cp. Biotechnol Bioeng. 2009 Oct 15;104(3):505-15. doi: 10.1002/bit.22415. Biotechnol Bioeng. 2009. PMID: 19557837

8

Vector insert-targeted integrative antisense expression system for plasmid stabilization.

Luke JM, Carnes AE, Hodgson CP, Williams JA. Luke JM, et al. Among authors: hodgson cp. Mol Biotechnol. 2011 Jan;47(1):43-9. doi: 10.1007/s12033-010-9310-5. Mol Biotechnol. 2011. PMID: 20607625

9

Critical design criteria for minimal antibiotic-free plasmid vectors necessary to combine robust RNA Pol II and Pol III-mediated eukaryotic expression with high bacterial production yields.

Carnes AE, Luke JM, Vincent JM, Anderson S, Schukar A, Hodgson CP, Williams JA. Carnes AE, et al. Among authors: hodgson cp. J Gene Med. 2010 Oct;12(10):818-31. doi: 10.1002/jgm.1499. J Gene Med. 2010. PMID: 20806425 Free PMC article.

10

Plasmid DNA fermentation strain and process-specific effects on vector yield, quality, and transgene expression.

Carnes AE, Luke JM, Vincent JM, Schukar A, Anderson S, Hodgson CP, Williams JA. Carnes AE, et al. Among authors: hodgson cp. Biotechnol Bioeng. 2011 Feb;108(2):354-63. doi: 10.1002/bit.22936. Biotechnol Bioeng. 2011. PMID: 20830679

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters